Posted by Michael Wonder on 09 Mar 2016

European scheme to develop drugs for diseases with no treatment launched

BMJ

8 March 2016 - Unlike the UK’s Early Access to Medicines scheme, PRIME does not shorten the authorisation procedure.

For more details, go to: http://www.bmj.com/content/352/bmj.i1385?etoc=

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Proposal , Orphan drug , Pharmaceutical industry , Innovation , Drug development